Correlation Between Valneva SE and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Altamira Therapeutics, you can compare the effects of market volatilities on Valneva SE and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Altamira Therapeutics.
Diversification Opportunities for Valneva SE and Altamira Therapeutics
0.92 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Valneva and Altamira is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Valneva SE and Altamira Therapeutics
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Altamira Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.79 times less risky than Altamira Therapeutics. The stock trades about -0.41 of its potential returns per unit of risk. The Altamira Therapeutics is currently generating about -0.2 of returns per unit of risk over similar time horizon. If you would invest 57.00 in Altamira Therapeutics on August 24, 2024 and sell it today you would lose (13.00) from holding Altamira Therapeutics or give up 22.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Valneva SE ADR vs. Altamira Therapeutics
Performance |
| Timeline |
| Valneva SE ADR |
| Altamira Therapeutics |
Valneva SE and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and Altamira Therapeutics
The main advantage of trading using opposite Valneva SE and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.| Valneva SE vs. Lyra Therapeutics | Valneva SE vs. Hookipa Pharma | Valneva SE vs. Cingulate Warrants | Valneva SE vs. SAB Biotherapeutics |
| Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |